Home › Stocks › AMED US-listed stock · AMED
Amedisys Inc (AMED): trades by Congress and insiders
No trades disclosed in the last 12 months; 6 disclosures on record in all.
Congress trades 012 months
Members trading 012 months
Insider buys / sales 0 / 012 months 6 disclosed buys and sales on record since 27 April 2020. Insider counts are open-market trades only: awards, option exercises and tax withholding are left out.
Members of Congress who traded AMED
Last three years, by number of disclosed trades.
Latest disclosures
Disclosed Filed by Type Amount Traded
12 Sep 2025 Lisa McClain House · R-MI Sale $1K–$15K
18 Aug 2025
13 Aug 2025 Lisa McClain House · R-MI Buy $1K–$15K
9 Jun 2025
3 Mar 2023 Ro Khanna House · D-CA Buy $1K–$15K
10 Feb 2023
9 Nov 2020 Greg Gianforte House · R-MT Sale $1K–$15K
13 Oct 2020
27 Apr 2020 Donna Shalala House · D-FL Sale $1K–$15K
16 Apr 2019
27 Apr 2020 Donna Shalala House · D-FL Sale $1K–$15K
24 Jun 2019
Columns are written from public disclosures: House and Senate periodic transaction reports, SEC Form 4, Japan’s EDINET large-holding reports and Taiwan’s insider registers and market data (TWSE, TPEx, MOPS and the central bank, with history from FinMind). Stock pages add SEC 13F fund holdings and company financials, analysts’ figures from Financial Modeling Prep and Finnhub, and lobbying and federal contract records from the Senate and USAspending.gov. Amounts are disclosed as ranges, so the figures are estimates. Nothing here is investment advice.
Home · Features · Columns · Members of Congress · Stocks · Sitemap · RSS feed of the columns · Privacy and security
Follow us on X Bluesky LinkedIn